ID

31378

Description

Study ID: 104507 Clinical Study ID: BEX104507 Study Title: Phase II Study of Iodine-131 Anti-B1 Antibody for Non Hodgkin’s Lymphoma Patients who have Previously Received Rituximab Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00996593 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: tositumomab Trade Name: Bexxar Study Indication: Lymphoma, Non-Hodgkin

Mots-clés

  1. 24/07/2018 24/07/2018 -
  2. 18/08/2018 18/08/2018 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

18 août 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Iodine-131 Anti-B1 Antibody for Non Hodgkin’s Lymphomas NCT00996593

Patient Withdrawal from Study

Date of withdrawal from study
Description

Date of withdrawal from study

Alias
UMLS CUI-1
C0422727
UMLS CUI-2
C0011008
Date of withdrawal from study
Description

Patient withdrawn from trial; Date in time

Type de données

date

Alias
UMLS CUI [1,1]
C0422727
UMLS CUI [1,2]
C0011008
Reason for withdrawal from study
Description

Reason for withdrawal from study

Alias
UMLS CUI-1
C0422727
UMLS CUI-2
C3146298
Reason for withdrawal from study (check primary reason only)
Description

Patient withdrawn from trial | Indication

Type de données

text

Alias
UMLS CUI [1,1]
C0422727
UMLS CUI [1,2]
C3146298
If patient was lost to follow-up, date of last contact
Description

Lost to Follow-Up | Date last contact

Type de données

date

Alias
UMLS CUI [1]
C1302313
UMLS CUI [2]
C0805839
If other reason for withdrawal from study, please specify
Description

Patient withdrawn from trial; Indication; Other; Specification

Type de données

text

Alias
UMLS CUI [1,1]
C0422727
UMLS CUI [1,2]
C3146298
UMLS CUI [1,3]
C0205394
UMLS CUI [1,4]
C2348235
Explanation of withdrawal
Description

Explanation of withdrawal

Alias
UMLS CUI-1
C0422727
UMLS CUI-2
C0681841
Explanation of withdrawal (when appropriate)
Description

Patient withdrawn from trial; explanation

Type de données

text

Alias
UMLS CUI [1,1]
C0422727
UMLS CUI [1,2]
C0681841

Similar models

Patient Withdrawal from Study

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Date of withdrawal from study
C0422727 (UMLS CUI-1)
C0011008 (UMLS CUI-2)
Patient withdrawn from trial; Date in time
Item
Date of withdrawal from study
date
C0422727 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item Group
Reason for withdrawal from study
C0422727 (UMLS CUI-1)
C3146298 (UMLS CUI-2)
Item
Reason for withdrawal from study (check primary reason only)
text
C0422727 (UMLS CUI [1,1])
C3146298 (UMLS CUI [1,2])
Code List
Reason for withdrawal from study (check primary reason only)
CL Item
Patient was lost to follow-up (explain below) (1)
CL Item
Patient wished to withdraw from study (explain below) (2)
CL Item
Patient received alternative therapy (explain below) (3)
CL Item
Patient had progressive disease (4)
CL Item
Patient died (5)
CL Item
Other (6)
Lost to Follow-Up | Date last contact
Item
If patient was lost to follow-up, date of last contact
date
C1302313 (UMLS CUI [1])
C0805839 (UMLS CUI [2])
Patient withdrawn from trial; Indication; Other; Specification
Item
If other reason for withdrawal from study, please specify
text
C0422727 (UMLS CUI [1,1])
C3146298 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
C2348235 (UMLS CUI [1,4])
Item Group
Explanation of withdrawal
C0422727 (UMLS CUI-1)
C0681841 (UMLS CUI-2)
Patient withdrawn from trial; explanation
Item
Explanation of withdrawal (when appropriate)
text
C0422727 (UMLS CUI [1,1])
C0681841 (UMLS CUI [1,2])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial